Form 4: Edesa Biotech CEO Receives Stock Grant
Insider Transaction (Form 4)
Pardeep Nijhawan, Chief Executive Officer, a Director and 10% owner of Edesa Biotech, Inc., received 5,714 shares of common stock on September 1, 2026.
Summary
- Grant/award: acquired 5,714 Common Shares on September 1, 2026; holds 899,100 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Pardeep Nijhawan — Director, Officer (Chief Executive Officer), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant/award | Common Shares | 5,714 | — | — | 899,100 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Grant/award (5,714 shares) |
Keywords
insider transaction, Form 4, EDSA, Edesa Biotech, Inc., neutral, Pardeep Nijhawan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.